Meg Jardine's Publications

About Meg Jardine's Publications

Honorary Professorial Fellow, The George Institute for Global Health
  • Associate Professor, Faculty of Medicine, UNSW Sydney

  • Effect of Canagliflozin on Total Cardiovascular Burden in Patients With Diabetes and Chronic Kidney Disease: A Post Hoc Analysis From the CREDENCE Trial

    Journal of the American Heart Association Date published:

  • The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial

    Diabetes & Metabolism Date published:

  • Risk Factors for Fracture in Patients with Coexisting Chronic Kidney Disease and Type 2 Diabetes: An Observational Analysis from the CREDENCE Trial

    Journal of Diabetes Research Date published:

  • Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy

    JAMA Date published:

  • Risk factors for incident kidney disease in older adults: an Australian prospective population-based study

    Internal Medicine Journal Date published:

  • Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial

    Trials Date published:

  • A Novel Risk Prediction Model for Severe Acute Kidney Injury in Intensive Care Unit Patients Receiving Fluid Resuscitation

    Frontiers in Cardiovascular Medicine Date published:

  • Premature Death in Kidney Transplant Recipients: The Time for Trials is Now

    Journal of the American Society of Nephrology Date published:

  • Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice

    International Journal of Cardiology Date published:

  • Potential Effects of Elimination of the Black Race Coefficient in eGFR Calculations in the CREDENCE Trial

    Clinical Journal of the American Society of Nephrology Date published:

  • Prior Cardiovascular Treatments-A Key Characteristic in Determining Medication Adherence After an Acute Myocardial Infarction

    Frontiers in Pharmacology Date published:

  • INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN-7 PREDICTS CARDIOVASCULAR AND RENAL OUTCOMES IN PATIENTS WITH TYPE 2 DIABETES AND CHRONIC KIDNEY DISEASE: THE CREDENCE TRIAL

    Journal of the American College of Cardiology Date published:

  • Antiplatelet agents for chronic kidney disease

    Cochrane Database of Systematic Reviews Date published:

  • SGLT2 inhibitors and finerenone: one or the other or both?

    Nephrology Dialysis Transplantation Date published:

  • Canagliflozin and Kidney-Related Adverse Events in Type 2 Diabetes and CKD: Findings From the Randomized CREDENCE Trial

    American Journal of Kidney Diseases Date published:

  • SGLT2 inhibitors may prevent diabetes

    Nature Reviews Nephrology Date published: